M&A Corner
Polaris Group Announced the Acquisition of Genovior Biotech, Initiating Dual-Engine Growth26 Dec 2023
Polaris Group solidifies its acquisition of Genovior Biotech’s shares to 100%, appointing Dr. Steve Hsu, an esteemed expert, as CEO.... Continue Reading
|
ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic.26 Dec 2023
Standard BioTools Inc. anticipates a favorable outcome at its upcoming stockholder meeting following ISS’s endorsement to vote “FOR” all proposals... Continue Reading
|
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics26 Dec 2023
Bristol Myers Squibb (BMS) is set to acquire Karuna Therapeutics for $14 billion, aiming to leverage Karuna’s lead asset, KarXT,... Continue Reading
|
BMS Closes the Year with $14B Karuna Buy to Bolster Neuro Portfolio26 Dec 2023
Bristol Myers Squibb’s merger agreement with Karuna Therapeutics for $14 billion aims to acquire KarXT, an innovative muscarinic antipsychotic designed... Continue Reading
|
Astellas Completes Acquisition of Propella Therapeutic26 Dec 2023
Astellas Pharma US, Inc. has finalized its acquisition of Propella Therapeutics, Inc., making it a wholly owned subsidiary. This strategic... Continue Reading
|
Guidehealth Acquires MSO & VBC Services Division from Arcadia26 Dec 2023
Guidehealth, an AI-driven healthcare platform, acquired Arcadia’s managed services arm and Value-Based Care Services while securing a technology pact to... Continue Reading
|
mPulse Acquires HealthTrio and Decision Point26 Dec 2023
mPulse, a prominent figure in digital health engagement, has acquired HealthTrio and Decision Point Healthcare Solutions, positioning itself as a... Continue Reading
|
Jefferson and Lehigh Valley Health Network Announce Merger26 Dec 2023
Jefferson Health and Lehigh Valley Health Network (LVHN) plan to merge, forming the “Jefferson Enterprise,” a robust healthcare system spanning... Continue Reading
|
CoachCare Acquires Verustat to Expand Remote Patient Monitoring Reach26 Dec 2023
CoachCare, a top remote patient monitoring (RPM) company, acquires Verustat, marking its fourth acquisition in a year. This move bolsters... Continue Reading
|
Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million26 Dec 2023
Neurogene (NASDAQ: NGNE), post-merger with Neoleukin, concludes a $95 million private financing round, enhancing its Rett syndrome-focused gene therapy, NGN-401.... Continue Reading
|